Viemed Healthcare, Inc. (VMD) Reports In-Line Q2 EPS

Viemed Healthcare, Inc. (NASDAQ: VMD) reported Q2 EPS of $0.06, in-line with the analyst estimate of $0.06. Revenue for the quarter came in at $43.3 million versus the consensus estimate of $40.83 million.

For earnings history and earnings-related data on Viemed Healthcare, Inc. (VMD) click here.

You May Also Be Interested In

• H&R Block (HRB) Tops Q4 EPS by 7c, Offers Guidance
• Pliant Therapeutics, Inc. (PLRX) Misses Q2 EPS by 2c
• Hour Loop, Inc. (HOUR) Reports Q2 EPS of $0.03